Gsk (GSK) Minority Interest (2009 - 2026)
Gsk (GSK) posted quarterly Minority Interest of -$627.9 million for Q2 2026, down 7.71% year-over-year from -$680.3 million in Q2 2025, and down 8.31% quarter-over-quarter from -$579.7 million in Q1 2026.
Gsk (GSK) Minority Interest (2009 - 2026) Analysis & Trends
Gsk's Minority Interest history runs 18 years deep, the most recent figure standing at -$627.9 million for Q2 2026.
- In Q2 2026, Minority Interest fell 7.71% year-over-year to -$627.9 million; the TTM figure through Jun 2026 stood at -$627.9 million (down 7.71% YoY), while the FY2025 annual figure was -$555.1 million, up 25.77% from the prior year.
- Minority Interest for Q2 2026 stood at -$627.9 million, down from -$579.7 million in the prior quarter.
- The five-year high for Minority Interest was $8.7 billion in Q1 2022, with the low at -$775.1 million in Q1 2024.
- The 5-year median for Minority Interest is -$622.7 million (2023), against an average of $350.0 million.
- The sharpest annual moves came in 2023 and 2025: Minority Interest slumped 108.44% in 2023, then gained 25.9% in 2025.
- Gsk's Minority Interest stood at -$588.8 million in 2022, then slipped by 16.36% to -$685.1 million in 2023, then fell by 9.59% to -$750.8 million in 2024, then rose by 25.42% to -$560.0 million in 2025, then fell by 12.13% to -$627.9 million in 2026.
- Business Quant data shows GSK's Minority Interest at -$627.9 million in Q2 2026, -$579.7 million in Q1 2026, and -$560.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -627.91 Mn |
| Mar 31, 2026 | -579.72 Mn |
| Dec 31, 2025 | -560.00 Mn |
| Sep 30, 2025 | -534.35 Mn |
| Jun 30, 2025 | -582.98 Mn |
| Mar 31, 2025 | -633.53 Mn |
| Dec 31, 2024 | -750.85 Mn |
| Sep 30, 2024 | -721.11 Mn |
| Jun 30, 2024 | -759.86 Mn |
| Mar 31, 2024 | -775.06 Mn |
| Dec 31, 2023 | -685.12 Mn |
| Sep 30, 2023 | -651.08 Mn |
| Jun 30, 2023 | -665.73 Mn |
| Mar 31, 2023 | -617.48 Mn |
| Dec 31, 2022 | -588.81 Mn |
| Sep 30, 2022 | -513.85 Mn |
| Jun 30, 2022 | 7.89 Bn |
| Mar 31, 2022 | 8.66 Bn |
| Dec 31, 2021 | 8.47 Bn |
| Sep 30, 2021 | 8.72 Bn |